Matthew M. Walsh - Aug 5, 2021 Form 4 Insider Report for Organon & Co. (OGN)

Role: Chief Financial Officer
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Stock symbol: OGN
Transactions as of: Aug 5, 2021
Transactions value $: $420,575
Form type: 4
Date filed: 8/9/2021, 04:44 PM
Previous filing: Jun 4, 2021
Next filing: Aug 19, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise	$640K	+22.3K		$28.63	22.3K	Aug 5, 2021	Direct
transaction	OGN	Common Stock	Tax liability	-$219K	-7.65K	-34.25%	$28.63	14.7K	Aug 5, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	+22.3K	+99.98%	$0.00	44.7K	Aug 5, 2021	Common Stock	22.3K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock.
F2	These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments on August 5, 2021, August 5, 2022 and August 5, 2023.